Susan H Fox Selected Research

Levodopa (L Dopa)

7/2022	Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease.
1/2020	Initiation of pharmacological therapy in Parkinson's disease: when, why, and how.
1/2020	Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an update.
1/2020	Hallucinations, Delusions and Impulse Control Disorders in Parkinson Disease.
1/2019	Viewpoint: Developing drugs for levodopa-induced dyskinesia in PD: Lessons learnt, what does the future hold?
1/2019	Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease.
1/2019	Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques.
12/2018	Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts.
11/2018	Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation.
11/2018	Pharmacokinetic/Pharmacodynamic Correlation Analysis of Amantadine for Levodopa-Induced Dyskinesia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan H Fox Research Topics

Disease

87	Parkinson Disease (Parkinson's Disease) 01/2022 - 11/2002
71	Dyskinesias (Dyskinesia) 07/2022 - 11/2002
15	Parkinsonian Disorders (Parkinsonism) 01/2022 - 07/2005
15	Psychotic Disorders (Schizoaffective Disorder) 01/2020 - 09/2006
6	Dystonia (Limb Dystonia) 07/2021 - 01/2002
6	Tremor (Tremors) 10/2020 - 09/2013
4	Disease Progression 07/2022 - 01/2010
4	Hallucinations (Hallucination) 09/2017 - 11/2004
4	Chorea (Rheumatic Chorea) 09/2014 - 06/2006
3	Sialorrhea 12/2020 - 11/2007
3	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2020 - 02/2011
3	Mood Disorders (Mood Disorder) 01/2018 - 12/2012
2	Cognitive Dysfunction 01/2019 - 05/2012
2	Pain (Aches) 01/2018 - 09/2016
2	Hypokinesia (Bradykinesia) 03/2015 - 05/2014
2	Gambling (Pathological Gambling) 10/2011 - 02/2007
1	Epilepsy (Aura) 07/2021
1	Torticollis (Wryneck) 07/2021
1	Huntington Disease (Huntington's Disease) 01/2019
1	Intractable Pain 09/2016
1	Dyspepsia (Indigestion) 03/2015
1	Diabetes Mellitus 03/2015

Drug/Important Bio-Agent (IBA)

70	Levodopa (L Dopa)FDA LinkGeneric 07/2022 - 11/2002
28	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2022 - 11/2002
17	Dopamine (Intropin)FDA LinkGeneric 10/2020 - 07/2005
11	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 01/2008
9	Amantadine (Aman)FDA LinkGeneric 10/2020 - 11/2006
9	Clozapine (Clozaril)FDA LinkGeneric 01/2020 - 11/2006
9	Pharmaceutical PreparationsIBA 01/2016 - 11/2005
5	Quetiapine Fumarate (Seroquel)FDA Link 01/2020 - 11/2006
5	Antipsychotic Agents (Antipsychotics)IBA 01/2016 - 11/2006
4	Dopamine Agonists (Dopamine Agonist)IBA 01/2020 - 11/2004
4	Cholinergic Antagonists (Anticholinergics)IBA 01/2020 - 11/2007
4	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 09/2017 - 04/2010
3	Apomorphine FDA Link 10/2020 - 11/2004
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016 - 01/2013
3	5-HT1A Serotonin ReceptorIBA 10/2015 - 01/2012
3	Dihydroxyphenylalanine (Dopa)IBA 06/2013 - 02/2009
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 12/2020 - 10/2011
2	Rivastigmine (Exelon)FDA LinkGeneric 10/2020 - 10/2011
2	N-Methylaspartate (NMDA)IBA 11/2018 - 09/2013
2	Type A Botulinum Toxins (Botox)FDA Link 01/2018 - 10/2011
2	oxidized low density lipoproteinIBA 01/2018 - 03/2013
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2016 - 03/2013
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2016 - 01/2015
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2016 - 09/2013
2	3- ((4- (4- chlorophenyl)piperazin- 1- yl)methyl)- 1H- pyrrolo(2,3- b)pyridineIBA 02/2015 - 08/2012
2	Famotidine (Pepcid)FDA LinkGeneric 09/2014 - 07/2010
2	N- methyl- 1- cyclopropyl- 1- piperonylmethylamineIBA 07/2014 - 01/2012
2	Antidepressive Agents (Antidepressants)IBA 09/2013 - 10/2011
2	fipamezoleIBA 09/2013 - 08/2003
2	Dopamine Agents (Dopaminergic Agents)IBA 09/2013 - 05/2012
2	Dopamine AntagonistsIBA 06/2013 - 01/2008
2	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 05/2012 - 01/2012
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 05/2012 - 05/2011
2	Pramipexole (Mirapex)FDA LinkGeneric 10/2011 - 10/2011
2	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 10/2011 - 11/2007
2	Pergolide (Permax)FDA Link 10/2011 - 10/2011
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 11/2002 - 01/2002
2	Cannabinoid Receptor AgonistsIBA 11/2002 - 01/2002
2	nabilone (Cesamet)FDA Link 11/2002 - 01/2002
1	Investigational DrugsIBA 07/2022
1	Excitatory Amino Acid AntagonistsIBA 07/2021
1	AMPA Receptors (AMPA Receptor)IBA 07/2021
1	perampanelIBA 07/2021
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 07/2021
1	Calcium Channels (Calcium Channel)IBA 10/2020
1	ElementsIBA 01/2019
1	pridopidineIBA 01/2019
1	Capsules (Microcapsules)IBA 11/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2018
1	CannabinoidsIBA 01/2018
1	DPI-289IBA 01/2018
1	safinamideIBA 02/2017
1	Sigma-1 ReceptorIBA 01/2017
1	Quinidine (Chinidin)FDA LinkGeneric 01/2017
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 01/2017
1	Botulinum Toxins (Botulinum Toxin)IBA 09/2016
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 01/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016
1	Dopamine Uptake Inhibitors (Dopamine Reuptake Inhibitors)IBA 01/2016
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016
1	3- chloro- 4- fluorophenyl- (4- fluoro- 4- (((5- methylpyrimidin- 2- ylmethyl)amino)methyl)piperidin- 1- yl)methanoneIBA 10/2015
1	Biomarkers (Surrogate Marker)IBA 08/2015
1	Urea (Carbamide)FDA LinkGeneric 03/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2015
1	PPAR gammaIBA 03/2015
1	Pioglitazone (Actos)FDA Link 03/2015
1	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 02/2015
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2015
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2015
1	Histamine H2 AntagonistsIBA 09/2014
1	Histamine H2 ReceptorsIBA 09/2014

Therapy/Procedure

25	Therapeutics 10/2020 - 11/2006
3	Drug Therapy (Chemotherapy) 01/2020 - 02/2017
2	Aftercare (After-Treatment) 01/2018 - 05/2012
2	Injections 01/2018 - 09/2016
2	Deep Brain Stimulation 07/2016 - 04/2011
2	Activities of Daily Living (ADL) 09/2014 - 05/2012